Abstract:Our study systematically examined the underlying mechanisms of Hypericum perforatum L. in the vascular cognitive impairment (VCI) model using network pharmacology. Our experiments demonstrated that hyperforin, the most potent ingredient in H. perforatum L., ameliorates microglial activation, white matter lesions, and ultimately improves cognitive function in VCI mice through the VEGFR2/SRC pathway. Aim To explore the neuroprotective potential of hyperforin and elucidate its underlying molecular mechanisms involved in its therapeutic effects against vascular cognitive impairment (VCI). Methods The active compounds and possible targets of Hypericum perforatum L. that may be effective against VCI were found by network pharmacology in this research. We utilized bilateral common carotid artery occlusion (BCCAO) surgery to induce a VCI mouse model. Morris water maze (MWM) and Y‐maze tests were used to assess VCI mice's cognitive abilities following treatment with hyperforin. To evaluate white matter lesions (WMLs), we utilized Luxol fast blue (LFB) stain and immunofluorescence (IF). Neuroinflammation was assessed using IF, western blot (WB), and enzyme‐linked immunosorbent assay (ELISA). The effects of hyperforin on microglia were investigated by subjecting the BV2 microglial cell line to oxygen–glucose deprivation/reperfusion (OGD/R) stimulation. The expressions of VEGFR2, p‐SRC, SRC, VEGFA, and inflammatory markers including IL‐10, IL‐1β, TNF‐α, and IL‐6 were subsequently assessed. Results The VEGFR2/SRC signaling pathway is essential for mediating the protective properties of hyperforin against VCI according to network pharmacology analysis. In vivo findings demonstrated that hyperforin effectively improved BCCAO‐induced cognitive impairment. Furthermore, staining results showed that hyperforin attenuated WMLs and reduced microglial activation in VCI mice. The hyperforin treatment group's ELISA results revealed a substantial decrease in IL‐1β, IL‐6, and TNF‐α levels. According to the results of in vitro experiments, hyperforin decreased the release of pro‐inflammatory mediators (TNF‐α, IL‐6, and IL‐1β) and blocked microglial M1‐polarization by modulating the VEGFR2/SRC signaling pathway. Conclusion Hyperforin effectively modulated microglial M1 polarization and neuroinflammation by inhibiting the VEGFR2/SRC signaling pathways, thereby ameliorating WMLs and cognitive impairment in VCI mice.

Hyperforin Promotes Post-stroke Neuroangiogenesis via Astrocytic IL-6-Mediated Negative Immune Regulation in the Ischemic Brain.

Hyperforin promotes post-stroke functional recovery through interleukin (IL)-17A-mediated angiogenesis

Hyperforin improves post-stroke social isolation‑induced exaggeration of PSD and PSA via TGF-β

Hyperforin ameliorates neuroinflammation and white matter lesions by regulating microglial VEGFR2/SRC pathway in vascular cognitive impairment mice

Buyang Huanwu Decoction Increases Angiopoietin-1 Expression and Promotes Angiogenesis and Functional Outcome after Focal Cerebral Ischemia.

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity.

Critical Role Of Astrocytic Interleukin-17 A In Post-Stroke Survival And Neuronal Differentiation Of Neural Precursor Cells In Adult Mice

Effect of hydroxysafflor yellow A on the activity of astrocytes in cerebral ischemic/reperfusion in rats

Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages

Buyang Huanwu Decoction promotes neurovascular remodeling by modulating astrocyte and microglia polarization in ischemic stroke rats

Postacute Stromal Cell–Derived Factor-1α Expression Promotes Neurovascular Recovery in Ischemic Mice

Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway

Enriched housing promotes post-stroke functional recovery through astrocytic HMGB1-IL-6-mediated angiogenesis.

Astrocytic Cytochrome P450 4A/20-Hydroxyeicosatetraenoic Acid Contributes to Angiogenesis in the Experimental Ischemic Stroke

Houshiheisan promotes angiogenesis via HIF-1α/VEGF and SDF-1/CXCR4 pathways: in vivo and in vitro

VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives neuroinflammation in mouse ischemic stroke

Low-intensity Focused Ultrasound Stimulation Promotes Stroke Recovery Via Astrocytic HMGB1 and CAMK2N1 in Mice

De novo Lipogenesis in Astrocytes Promotes the Repair of Blood–Brain Barrier after Transient Cerebral Ischemia Through Interleukin-33

Neuroprotective Effects of Hesperetin in Regulating Microglia Polarization after Ischemic Stroke by Inhibiting TLR4/NF-κB Pathway

Optogenetic Activation of Astrocytes Reduces Blood-Brain Barrier Disruption Via IL-10 in Stroke.

Interleukin-4 Regulation on Angiogenesis in Ischemic Stroke